Literature DB >> 22517102

High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis.

D Callacondo1, H H Garcia, I Gonzales, D Escalante, T E Nash.   

Abstract

OBJECTIVE: To determine the frequency of spinal neurocysticercosis (NCC) in patients with basal subarachnoid NCC compared with that in individuals with viable limited intraparenchymal NCC (≤20 live cysts in the brain).
METHODS: We performed a prospective observational case-control study of patients with NCC involving the basal cisterns or patients with only limited intraparenchymal NCC. All patients underwent MRI examinations of the brain and the entire spinal cord to assess spinal involvement.
RESULTS: Twenty-seven patients with limited intraparenchymal NCC, and 28 patients with basal subarachnoid NCC were included in the study. Spinal involvement was found in 17 patients with basal subarachnoid NCC and in only one patient with limited intraparenchymal NCC (odds ratio 40.18, 95% confidence interval 4.74-340.31; p < 0.0001). All patients had extramedullary (intradural) spinal NCC, and the lumbosacral region was the most frequently involved (89%). Patients with extensive spinal NCC more frequently had ventriculoperitoneal shunt placement (7 of 7 vs 3 of 11; p = 0.004) and tended to have a longer duration of neurologic symptoms than those with regional involvement (72 months vs 24 months; p = 0.062).
CONCLUSIONS: The spinal subarachnoid space is commonly involved in patients with basal subarachnoid NCC, compared with those with only intraparenchymal brain cysts. Spinal cord involvement probably explains serious late complications including chronic meningitis and gait disorders that were described before the introduction of antiparasitic therapy. MRI of the spine should be performed in basal subarachnoid disease to document spinal involvement, prevent complications, and monitor for recurrent disease.

Entities:  

Mesh:

Year:  2012        PMID: 22517102      PMCID: PMC3345784          DOI: 10.1212/WNL.0b013e318253d641

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Ununsual manifestations of neurocysticercosis in MR imaging: analysis of 172 cases.

Authors:  Lázaro Amaral; Murilo Maschietto; Roberta Maschietto; Ricardo Cury; Nelson Fortes Ferreira; Renato Mendonça; Sérgio Santos Lima
Journal:  Arq Neuropsiquiatr       Date:  2003-09-16       Impact factor: 1.420

2.  CYSTICERCOSIS OF THE NERVOUS SYSTEM: LESS FREQUENT CLINICAL FORMS. III. SPINAL CORD FORMS.

Authors:  H M CANELAS; O RICCIARDI-CRUZ; A D ESCALANTE
Journal:  Arq Neuropsiquiatr       Date:  1963-06       Impact factor: 1.420

3.  Cysticercosis of the posterior fossa.

Authors:  E R BICKERSTAFF; J M SMALL; A L WOOLF
Journal:  Brain       Date:  1956-12       Impact factor: 13.501

4.  MRI demonstration of subarachnoid neurocysticercosis simulating metastatic disease.

Authors:  K Y Lau; D J Roebuck; V Mok; H K Ng; J Lam; J G Teo; R Kay; W Poon; C Metreweli
Journal:  Neuroradiology       Date:  1998-11       Impact factor: 2.804

5.  Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up.

Authors:  Raúl J Bobes; Marisela Hernández; Carlos Márquez; Gladis Fragoso; Esperanza García; R Michael E Parkhouse; Leslie J S Harrison; Edda Sciutto; Agnès Fleury
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

6.  Spinal cord cysticercosis: neurosurgical aspects.

Authors:  Benedito Oscar Colli; Marcelo Moraes Valença; Carlos Gilberto Carlotti; Helio Rubens Machado; João Alberto Assirati
Journal:  Neurosurg Focus       Date:  2002-06-15       Impact factor: 4.047

Review 7.  Neurocysticercosis: updated concepts about an old disease.

Authors:  Hector H Garcia; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

8.  Intramedullary cysticercosis. Case report, literature review and comments on pathogenesis.

Authors:  L De Souza Queiroz; A P Filho; D Callegaro; L L De Faria
Journal:  J Neurol Sci       Date:  1975-09       Impact factor: 3.181

9.  MR imaging of intramedullary and intradural-extramedullary spinal cysticercosis.

Authors:  C C Leite; J R Jinkins; B E Escobar; A C Magalhães; G C Gomes; G Dib; S A Vargas; C Zee; A T Watanabe
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

Review 10.  Extraparenchymal neurocysticercosis: report of five cases and review of management.

Authors:  J C Bandres; A C White; T Samo; E C Murphy; R L Harris
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

View more
  24 in total

Review 1.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

Review 2.  Current status and future perspectives on the medical treatment of neurocysticercosis.

Authors:  Isidro Gonzales; Hector H Garcia
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 3.  Spinal Taenia solium cysticercosis in Mexican and Indian patients: a comparison of 30-year experience in two neurological referral centers and review of literature.

Authors:  Graciela Cárdenas; Erik Guevara-Silva; Felipe Romero; Yair Ugalde; Cecilia Bonnet; Agnes Fleury; Edda Sciutto; Caris Maroni Nunes; José Luis Soto-Hernández; Susarla Krishna Shankar; Anita Mahadevan
Journal:  Eur Spine J       Date:  2015-10-16       Impact factor: 3.134

Review 4.  Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review.

Authors:  S Purvey; K Lu; S K Mukkamalla; P Anandi; B Dumitriu; S Kranick; D A Hammoud; E O'Connell; A L Oh; J Barrett; S Mahanty; M Battiwalla
Journal:  Transpl Infect Dis       Date:  2015-06-01       Impact factor: 2.228

5.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

Review 6.  Update on the Diagnosis and Management of Neurocysticercosis.

Authors:  Camille M Webb; A Clinton White
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

Review 7.  Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.

Authors:  Andrea Sylvia Winkler
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 8.  Taenia solium Taeniasis and Cysticercosis in Southeast Asia.

Authors:  Ar Kar Aung; Denis W Spelman
Journal:  Am J Trop Med Hyg       Date:  2016-02-01       Impact factor: 2.345

9.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

10.  Mortality in Parenchymal and Subarachnoid Neurocysticercosis.

Authors:  Jesus Abanto; Daniel Blanco; Herbert Saavedra; Isidro Gonzales; Diego Siu; E Javier Pretell; Javier A Bustos; Hector H Garcia
Journal:  Am J Trop Med Hyg       Date:  2021-07-07       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.